These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32026047)

  • 1. Therapeutic experience with tramadol for opioid dependence in a patient with chronic low back pain: a case report.
    Shigematsu-Locatelli M; Kawano T; Koyama T; Iwata H; Nishigaki A; Aoyama B; Tateiwa H; Kitaoka N; Yokoyama M
    JA Clin Rep; 2019 Oct; 5(1):68. PubMed ID: 32026047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved cancer pain treatment using combined fentanyl-TTS and tramadol.
    Marinangeli F; Ciccozzi A; Aloisio L; Colangeli A; Paladini A; Bajocco C; Coaccioli S; Varrassi G
    Pain Pract; 2007 Dec; 7(4):307-12. PubMed ID: 17986161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Home palliative care--2 case reports: a long-term cancer pain management with transdermal fentanyl].
    Fujimoto M; Sakuyama T; Mizutani Y; Kuroda T; Yanaga K
    Gan To Kagaku Ryoho; 2004 Dec; 31 Suppl 2():190-3. PubMed ID: 15645768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study.
    Karlsson M; Berggren AC
    Clin Ther; 2009 Mar; 31(3):503-13. PubMed ID: 19393841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-reported utilization patterns of fentanyl transdermal system and oxycodone hydrochloride controlled-release among patients with chronic nonmalignant pain.
    Ackerman SJ; Mordin M; Reblando J; Xu X; Schein J; Vallow S; Brennan M
    J Manag Care Pharm; 2003; 9(3):223-31. PubMed ID: 14613465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The problem of pain: Additive analgesic effect of tramadol and buprenorphine in a patient with opioid use disorder.
    Montalvo C; Genovese N; Renner J
    Subst Abus; 2019; 40(2):136-139. PubMed ID: 30835647
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral tramadol and buprenorphine in tumour pain. An Italian multicentre trial.
    Brema F; Pastorino G; Martini MC; Gottlieb A; Luzzani M; Libretti A; Saccà L; Cigolari S
    Int J Clin Pharmacol Res; 1996; 16(4-5):109-16. PubMed ID: 9172009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, placebo-controlled study of a new sublingual formulation of fentanyl citrate (fentanyl ethypharm) for breakthrough pain in opioid-treated patients with cancer.
    Novotna S; Valentova K; Fricova J; Richterova E; Harabisova S; Bullier F; Trinquet F;
    Clin Ther; 2014 Mar; 36(3):357-67. PubMed ID: 24508417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control.
    Muijsers RB; Wagstaff AJ
    Drugs; 2001; 61(15):2289-307. PubMed ID: 11772140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fentanyl tolerance in the treatment of cancer pain: a case of successful opioid switching from fentanyl to oxycodone at a reduced equivalent dose.
    Sutou I; Nakatani T; Hashimoto T; Saito Y
    J Pain Palliat Care Pharmacother; 2015 Jun; 29(2):161-5. PubMed ID: 26095488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Switching opioids to transdermal fentanyl in a clinical setting].
    Elsner F; Radbruch L; Sabatowski R; Brunsch-Radbruch A; Loick G; Grond S
    Schmerz; 1999 Aug; 13(4):273-8. PubMed ID: 12799928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Noncancer Pain and Opioid Addiction: Diagnostic and Management Challenges.
    Kathiresan P; Rao R; Joshi T; Bhad R; Bhatnagar S; Deb KS; Chadda RK
    Indian J Palliat Care; 2020; 26(4):544-547. PubMed ID: 33623322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Not so patchy story of attempted suicide…leading to 24 hours of deep sleep and survival!
    Trist AJ; Sahota H; Williams L
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28096225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Concomitant use of strong and weak opioids in the management of chronic cancer pain].
    Bilen A; Ali A; Baturay F; Ozcan B; Altan A
    Agri; 2013; 25(1):7-12. PubMed ID: 23588864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control.
    Jeal W; Benfield P
    Drugs; 1997 Jan; 53(1):109-38. PubMed ID: 9010652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of TTS fentanyl as a single opioid for cancer pain relief: a safety and efficacy clinical trial in patients naive to mild or strong opioids.
    Mystakidou K; Befon S; Tsilika E; Dardoufas K; Georgaki S; Vlahos L
    Oncology; 2002; 62(1):9-16. PubMed ID: 11810038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects.
    Chawla JM; Pal H; Lal R; Jain R; Schooler N; Balhara YP
    J Opioid Manag; 2013; 9(1):35-41. PubMed ID: 23709302
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.